Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AxoGen, Inc. stock logo
AXGN
AxoGen
$10.92
-1.3%
$11.70
$7.33
$21.00
$497.30M1.04492,421 shs169,683 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$3.17
$2.94
$1.93
$4.39
$268.88M0.9949,139 shs21,921 shs
Embecta Corp. stock logo
EMBC
Embecta
$10.32
+0.7%
$10.91
$9.20
$21.48
$603.10M1.08497,820 shs291,940 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$61.83
+0.5%
$56.44
$42.34
$63.29
$786.48M0.9144,009 shs69,139 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AxoGen, Inc. stock logo
AXGN
AxoGen
0.00%+4.00%0.00%-34.30%+44.83%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.00%+6.38%+4.97%+29.39%+43.44%
Embecta Corp. stock logo
EMBC
Embecta
0.00%+7.05%+5.41%-14.64%-9.95%
iRadimed Corporation stock logo
IRMD
iRadimed
0.00%+1.63%+2.20%+25.24%+41.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AxoGen, Inc. stock logo
AXGN
AxoGen
2.0134 of 5 stars
3.52.00.00.00.02.50.6
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
1.8528 of 5 stars
3.53.00.00.00.61.70.0
Embecta Corp. stock logo
EMBC
Embecta
4.1386 of 5 stars
3.21.03.30.00.03.33.8
iRadimed Corporation stock logo
IRMD
iRadimed
3.942 of 5 stars
2.52.02.54.40.03.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AxoGen, Inc. stock logo
AXGN
AxoGen
3.00
Buy$24.50124.36% Upside
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
3.00
Buy$8.00152.37% Upside
Embecta Corp. stock logo
EMBC
Embecta
2.33
Hold$19.3387.34% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$72.0016.45% Upside

Current Analyst Ratings Breakdown

Latest DRTS, AXGN, EMBC, and IRMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$25.00
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.00
5/13/2025
AxoGen, Inc. stock logo
AXGN
AxoGen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $24.00
4/29/2025
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/10/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$15.00
4/9/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AxoGen, Inc. stock logo
AXGN
AxoGen
$187.34M2.65N/AN/A$2.36 per share4.63
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/A$0.89 per shareN/A
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.54$3.34 per share3.09($12.80) per share-0.81
iRadimed Corporation stock logo
IRMD
iRadimed
$73.24M10.74$1.58 per share39.06$6.85 per share9.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AxoGen, Inc. stock logo
AXGN
AxoGen
-$9.96M-$0.15N/AN/AN/A-3.68%-7.09%-3.67%8/6/2025 (Estimated)
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$31.75M-$0.46N/AN/AN/AN/A-49.48%-36.69%8/13/2025 (Estimated)
Embecta Corp. stock logo
EMBC
Embecta
$78.30M$0.9011.473.360.664.89%-19.67%12.27%8/8/2025 (Estimated)
iRadimed Corporation stock logo
IRMD
iRadimed
$19.23M$1.5539.8930.92N/A26.33%23.28%20.59%7/30/2025 (Estimated)

Latest DRTS, AXGN, EMBC, and IRMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q1 2025
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$0.14-$0.12+$0.02-$0.12$0.03 millionN/A
5/9/2025Q2 2025
Embecta Corp. stock logo
EMBC
Embecta
$0.66$0.70+$0.04$0.40$261.77 million$259.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$0.605.81%N/A66.67%N/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.681.10%N/A43.87%1 Years

Latest DRTS, AXGN, EMBC, and IRMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.154.51%5/28/20255/28/20256/13/2025
5/5/2025
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AxoGen, Inc. stock logo
AXGN
AxoGen
0.63
4.28
2.65
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.10
5.81
5.81
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.48
1.83
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
8.87
7.62

Institutional Ownership

CompanyInstitutional Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.65%
Embecta Corp. stock logo
EMBC
Embecta
93.83%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%

Insider Ownership

CompanyInsider Ownership
AxoGen, Inc. stock logo
AXGN
AxoGen
2.78%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
39.50%
Embecta Corp. stock logo
EMBC
Embecta
0.42%
iRadimed Corporation stock logo
IRMD
iRadimed
36.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
45045.54 million44.28 millionOptionable
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
8084.82 million51.32 millionNo Data
Embecta Corp. stock logo
EMBC
Embecta
2,10058.44 million58.20 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.72 million8.04 millionOptionable

Recent News About These Companies

New Strong Sell Stocks for June 12th
Iradimed Corp Bottom Line Rises In Q1
Iradimed Announces Quarterly Results
iRadimed Corporation Common Stock (IRMD)
Undiscovered Gems in the US Market for April 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

AxoGen stock logo

AxoGen NASDAQ:AXGN

$10.92 -0.14 (-1.27%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTS

$3.17 0.00 (0.00%)
As of 07/3/2025 03:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Embecta stock logo

Embecta NASDAQ:EMBC

$10.32 +0.07 (+0.68%)
Closing price 07/3/2025 03:35 PM Eastern
Extended Trading
$10.32 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$61.83 +0.29 (+0.47%)
As of 07/3/2025 01:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.